cbdMD Statistics
Total Valuation
cbdMD has a market cap or net worth of $7.30 million. The enterprise value is $6.68 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
cbdMD has 8.91 million shares outstanding. The number of shares has increased by 95.06% in one year.
| Current Share Class | 8.91M |
| Shares Outstanding | 8.91M |
| Shares Change (YoY) | +95.06% |
| Shares Change (QoQ) | +36.80% |
| Owned by Insiders (%) | 1.74% |
| Owned by Institutions (%) | 2.33% |
| Float | 8.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.03 |
| Forward PS | 0.67 |
| PB Ratio | 0.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 1.72.
| Current Ratio | 0.63 |
| Quick Ratio | 0.29 |
| Debt / Equity | 1.72 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | n/a |
| Interest Coverage | -118.87 |
Financial Efficiency
Return on equity (ROE) is -8.46% and return on invested capital (ROIC) is -14.91%.
| Return on Equity (ROE) | -8.46% |
| Return on Assets (ROA) | -6.23% |
| Return on Invested Capital (ROIC) | -14.91% |
| Return on Capital Employed (ROCE) | -119.21% |
| Revenue Per Employee | $466,503 |
| Profits Per Employee | -$99,113 |
| Employee Count | 42 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 2.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.53% in the last 52 weeks. The beta is 2.43, so cbdMD's price volatility has been higher than the market average.
| Beta (5Y) | 2.43 |
| 52-Week Price Change | -83.53% |
| 50-Day Moving Average | 1.27 |
| 200-Day Moving Average | 3.00 |
| Relative Strength Index (RSI) | 31.55 |
| Average Volume (20 Days) | 92,469 |
Short Selling Information
The latest short interest is 108,784, so 1.22% of the outstanding shares have been sold short.
| Short Interest | 108,784 |
| Short Previous Month | 102,825 |
| Short % of Shares Out | 1.22% |
| Short % of Float | 1.24% |
| Short Ratio (days to cover) | 0.59 |
Income Statement
In the last 12 months, cbdMD had revenue of $19.59 million and -$4.16 million in losses. Loss per share was -$6.05.
| Revenue | 19.59M |
| Gross Profit | 12.22M |
| Operating Income | -1.27M |
| Pretax Income | -21.65M |
| Net Income | -4.16M |
| EBITDA | -111,230 |
| EBIT | -1.27M |
| Loss Per Share | -$6.05 |
Full Income StatementBalance Sheet
The company has $1.77 million in cash and $1.15 million in debt, giving a net cash position of $620,129 or $0.07 per share.
| Cash & Cash Equivalents | 1.77M |
| Total Debt | 1.15M |
| Net Cash | 620,129 |
| Net Cash Per Share | $0.07 |
| Equity (Book Value) | 665,798 |
| Book Value Per Share | 0.84 |
| Working Capital | -3.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50,270 and capital expenditures -$189,893, giving a free cash flow of -$240,163.
| Operating Cash Flow | -50,270 |
| Capital Expenditures | -189,893 |
| Free Cash Flow | -240,163 |
| FCF Per Share | -$0.03 |
Full Cash Flow StatementMargins
Gross margin is 62.35%, with operating and profit margins of -6.49% and -0.81%.
| Gross Margin | 62.35% |
| Operating Margin | -6.49% |
| Pretax Margin | -0.81% |
| Profit Margin | -0.81% |
| EBITDA Margin | -0.57% |
| EBIT Margin | -6.49% |
| FCF Margin | n/a |
Dividends & Yields
cbdMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -95.06% |
| Shareholder Yield | -95.06% |
| Earnings Yield | -56.99% |
| FCF Yield | -3.29% |
Analyst Forecast
The average price target for cbdMD is $3.00, which is 265.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 265.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 7, 2025. It was a reverse split with a ratio of 0.125:1.
| Last Split Date | May 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.125:1 |
Scores
cbdMD has an Altman Z-Score of -22.48 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -22.48 |
| Piotroski F-Score | 2 |